SCHEMBL27173079

SCHEMBL27173079

CCOS(=O)(=O)c1ccc(C)cc1OCCOS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ MEN1 O00255 5/20 0.38
▸ KMT2A Q03164 5/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ GAA P10253 3/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ POLB P06746 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ MAPT P10636 4/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18613996 0.96 CA12 (0.43) CA12CA1CA9L3MBTL1KDM4E
SCHEMBL30828333 0.85 CA12 (0.46) CA12CA1CA9L3MBTL1KDM4E
SCHEMBL21219198 0.85 ALDH1A1 (0.41) L3MBTL1KDM4EMEN1KMT2AALDH1A1
SCHEMBL4420431 0.85 L3MBTL1 (0.42) L3MBTL1KDM4EMEN1KMT2AALDH1A1
SCHEMBL28541140 0.84 ALDH1A1 (0.43) L3MBTL1KDM4EMEN1KMT2AALDH1A1
SCHEMBL28560305 0.83 KMT2A (0.46) CA12CA1CA9MEN1KMT2A
SCHEMBL21815478 0.83 MEN1 (0.47) CA1CA9L3MBTL1MEN1KMT2A
SCHEMBL28380826 0.82 TSHR (0.39) CA1CA9L3MBTL1KDM4EMEN1
SCHEMBL27208962 0.82 MAPT (0.40) CA1CA9L3MBTL1KDM4EMEN1
SCHEMBL28354485 0.82 TSHR (0.39) CA1CA9L3MBTL1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337259-A1 COMPOUNDS FOR DEGRADING ALPHA-SYNUCLEIN AGGREGATES AND USES THEREOF Aprinoia Therapeutics Limited (HK) 2024-03-20 — — EP disclosed
Send feedback